Frequently asked questions Is IGF-1 LR3 legal to purchase
CJC-1295 w/o DAC 5 mg + Ipamorelin 5 mg CAS Numbers: CJC-1295 w/o DAC: 863288-34-0 Ipamorelin: 170851-70-4 PubChem CIDs: CJC-1295 w/o DAC: 10483373 Ipamorelin: 9941283 ChemSpider IDs: CJC-1295 w/o DAC: 23258162 Ipamorelin: 23231362 Molecular Formulas: CJC-1295 w/o DAC: CHNO Ipamorelin: CHNO Molecular Weights: CJC-1295 w/o DAC: ~3367.88 g/mol Ipamorelin: ~711.9 g/mol Content: Lyophilised blend (1:1 ratio, 5 mg each) Key Features Purity: 98% (HPLC-verified) Form: Freeze-dried (lyophilised) powder Documentation: Certificate of Analysis (COA) provided for each batch Origin: UK-stocked for rapid, tracked Royal Mail delivery Storage: 20 C in a temperature-controlled facility until dispatch Third party testing: Molecular Information CJC-1295 w/o DAC and Ipamorelin are synthetic peptides supplied as a high-purity lyophilised blend for controlled laboratory studies, analytical workflows, and in-vitro experimental applications
Less Common and Serious Side Effects While rare, there are more significant adverse effects of NAD IV therapy that should not be overlooked: Anaphylactoid or allergic reactions: Skin rash, bronchospasm, or low blood pressure in sensitive individuals Sudden, significant rises in inflammation markers (hs-CRP), seen in up to 70% of patients Glucose intolerance or signs of liver toxicity, especially with concurrent oral NAD supplementation or long-term use Injection site infection: Redness, excessive swelling, warmth, or pus at the administration site Exacerbation of underlying mood disorders or confusion These serious risks are much less common with a single, medically supervised NAD infusion, but high doses, frequent treatments, or improper administration, particularly outside of a trained medical office, raise the likelihood dramatically
It has been well worth the time and money for a thorough treatment plan
Sermorelin has a longer clinical track record and a shorter half-life, making it easier to adjust quickly
